Glycobiology Advance Access originally published online on September 26, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glycobiology, 2003, Vol. 13, No. 12 105R-115R
© 2003 Oxford University Press
REVIEW |
Devising a pathway for hyaluronan catabolism: are we there yet?
Department of Pathology, School of Medicine, 513 Parnassus Avenue, S-564, University of California San Francisco, San Francisco, CA 94143-0511
Received on April 21, 2003; revised on July 31, 2003; accepted on August 12, 2003
Hyaluronan is a negatively charged, high molecular weight glycosaminoglycan found predominantly in the extracellular matrix. Intracellular locations for hyaluronan have also been documented in cytoplasm, nucleus, and nucleolus. The polymer has an extraordinarily high rate of turnover in vertebrate tissues. The focus here is to formulate a metabolic pathway for hyaluronan degradation using all available data, including the recently acquired information on the hyaluronidase gene family. Such a catabolic scheme has defied explication up to now. In somatic tissues, stepwise processing occurs, from the extracellular high molecular weight space filling, antiangiogenic 
107-kDa polymer, to intermediate sized highly angiogenic, inflammatory, and immune-stimulating fragments, and ultimately to tetrasaccharides that are antiapoptotic and potent inducers of heat-shock proteins. It is proposed that the high molecular weight extracellular polymer is tethered to the cell surface by the combined efforts of hyaluronan receptors and hyaluronidase-2 (Hyal-2). The hyaluronan is cleaved to a 20-kDa intermediate-sized fragment, the limit product of Hyal-2 digestion. These fragments are delivered to endosomal- and ultimately lysosomal-like structures. Further catabolism occurs there by Hyal-1, coordinated with the activity of two lysosomal ß-exoglycosidases, ß-glucuronidase and ß-N-acetyl-glucosaminidase. A membrane-associated mini-organelle is postulated, the hyaluronasome, in which coordinated synthetic and catabolic enzyme reactions occur. The hyaluronasome can respond to the physiological states of the cell by a series of membrane-bound and soluble hyaluronan-associated receptors, binding proteins, and cofactors that trigger enzymatic events and signal transduction pathways. These in turn can be modulated by the amounts and sizes of the hyaluronan polysaccharides generated in the catabolic cascade. Most of these highly dynamic interactions remain to be determined. It is also proposed that malignant cells can commandeer some of these interactions for facilitating tumor growth and spread.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Duterme, J. Mertens-Strijthagen, M. Tammi, and B. Flamion Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions J. Biol. Chem., November 27, 2009; 284(48): 33495 - 33508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. May, R. A. Splain, C. Brotschi, and L. L. Kiessling A tethering mechanism for length control in a processive carbohydrate polymerization PNAS, July 21, 2009; 106(29): 11851 - 11856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yadav, R. L. A. Prasad, B. K. Jha, V. Rai, V. Bhakuni, and K. Datta Evidence for Inhibitory Interaction of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae Hyaluronidase J. Biol. Chem., February 6, 2009; 284(6): 3897 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Sakr, S. Potter-Perigo, M. G. Kinsella, P. Y. Johnson, K. R. Braun, Y. Goueffic, M. E. Rosenfeld, and T. N. Wight Hyaluronan Accumulation Is Elevated in Cultures of Low Density Lipoprotein Receptor-deficient Cells and Is Altered by Manipulation of Cell Cholesterol Content J. Biol. Chem., December 26, 2008; 283(52): 36195 - 36204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Monzon, D. Manzanares, N. Schmid, S. M. Casalino-Matsuda, and R. M. Forteza Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hemming, D. C. Martin, E. Slominski, J. I. Nagy, A. J. Halayko, S. Pind, and B. Triggs-Raine Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells Glycobiology, April 1, 2008; 18(4): 280 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Weigel and P. L. DeAngelis Hyaluronan Synthases: A Decade-plus of Novel Glycosyltransferases J. Biol. Chem., December 21, 2007; 282(51): 36777 - 36781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dai, T. Freudenberger, P. Zipper, A. Melchior, S. Grether-Beck, B. Rabausch, J. de Groot, S. Twarock, H. Hanenberg, B. Homey, et al. Chronic Ultraviolet B Irradiation Causes Loss of Hyaluronic Acid from Mouse Dermis Because of Down-Regulation of Hyaluronic Acid Synthases Am. J. Pathol., November 1, 2007; 171(5): 1451 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gerecht, J. A. Burdick, L. S. Ferreira, S. A. Townsend, R. Langer, and G. Vunjak-Novakovic Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells PNAS, July 3, 2007; 104(27): 11298 - 11303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Moring, J. R. Baker, and T. T. Norton Modulation of Glycosaminoglycan Levels in Tree Shrew Sclera during Lens-Induced Myopia Development and Recovery Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 2947 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Singleton, S. M. Dudek, S.-F. Ma, and J. G. N. Garcia Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation: NOVEL ROLE FOR HYALURONAN AND CD44 RECEPTOR FAMILY J. Biol. Chem., November 10, 2006; 281(45): 34381 - 34393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Simpson Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice Am. J. Pathol., July 1, 2006; 169(1): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rubio-Gayosso, S. H. Platts, and B. R. Duling Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tzircotis, R. F. Thorne, and C. M. Isacke Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding J. Cell Sci., November 1, 2005; 118(21): 5119 - 5128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vigdorovich, R. K. Strong, and A. D. Miller Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2 J. Virol., January 1, 2005; 79(1): 79 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Straach, J. M. Shelton, J. A. Richardson, V. C. Hascall, and M. S. Mahendroo Regulation of hyaluronan expression during cervical ripening Glycobiology, January 1, 2005; 15(1): 55 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Evanko, W. T. Parks, and T. N. Wight Intracellular Hyaluronan in Arterial Smooth Muscle Cells: Association with Microtubules, RHAMM, and the Mitotic Spindle J. Histochem. Cytochem., December 1, 2004; 52(12): 1525 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Jenkins, G. J. Thomas, J. D. Williams, and R. Steadman Myofibroblastic Differentiation Leads to Hyaluronan Accumulation through Reduced Hyaluronan Turnover J. Biol. Chem., October 1, 2004; 279(40): 41453 - 41460. [Abstract] [Full Text] [PDF]
|
|